Literature DB >> 22250798

Determination of lumefantrine in small-volume human plasma by LC-MS/MS: using a deuterated lumefantrine to overcome matrix effect and ionization saturation.

Liusheng Huang1, Xiaohua Li, Florence Marzan, Patricia S Lizak, Francesca T Aweeka.   

Abstract

BACKGROUND: To support pediatric study, a method to determine lumefantrine (LF) with small sample volume is needed. Matrix effect (ME) is a daunting issue in LF quantification in human plasma with LC-MS/MS.
RESULTS: Here we report an LC-MS/MS method with a deuterated LF as the internal standard (IS). Plasma sample (25 µl) was acidified with 5% formic acid prior to extraction with ethyl acetate. The recovery was over 80%. The absolute ME was within the range of 100 ± 8% for both LF and the IS, but cumulative ME was observed via large variation of IS signal. The cumulative ME and ionization saturation were overcome with the co-eluting LF-D(9) as the IS. The linear range of calibration curve was 50-20,000 ng/ml.
CONCLUSION: ME and ionization saturation was overcome with a deuterated IS. The method utilized a small sample volume, suitable for pediatric study with capillary tube blood collection method.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22250798      PMCID: PMC3321395          DOI: 10.4155/bio.11.303

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  18 in total

1.  Binding of artemether and lumefantrine to plasma proteins and erythrocytes.

Authors:  D Colussi; C Parisot; F Legay; G Lefèvre
Journal:  Eur J Pharm Sci       Date:  1999-10       Impact factor: 4.384

2.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

Authors:  B K Matuszewski; M L Constanzer; C M Chavez-Eng
Journal:  Anal Chem       Date:  2003-07-01       Impact factor: 6.986

3.  High throughput assay for the determination of lumefantrine in plasma.

Authors:  A Annerberg; T Singtoroj; P Tipmanee; N J White; N P J Day; N Lindegårdh
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-08-05       Impact factor: 3.205

4.  Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects.

Authors:  N Lindegardh; A Annerberg; N J White; N P J Day
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-12-24       Impact factor: 3.205

5.  Development and validation of a bioanalytical method using automated solid-phase extraction and LC-UV for the simultaneous determination of lumefantrine and its desbutyl metabolite in plasma.

Authors:  N Lindegårdh; A Annerberg; D Blessborn; Y Bergqvist; N Day; N J White
Journal:  J Pharm Biomed Anal       Date:  2005-04-29       Impact factor: 3.935

6.  Measurement of lumefantrine and its metabolite in plasma by high performance liquid chromatography with ultraviolet detection.

Authors:  Insaf F Khalil; Ulla Abildrup; Lene H Alifrangis; Deogratius Maiga; Michael Alifrangis; Lotte Hoegberg; Lasse S Vestergaard; Ola Per-Eric Persson; Nyagonde Nyagonde; Martha M Lemnge; Thor G Theander; Ib C Bygbjerg
Journal:  J Pharm Biomed Anal       Date:  2010-08-17       Impact factor: 3.935

7.  Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.

Authors:  Elizabeth A Ashley; Kasia Stepniewska; Niklas Lindegårdh; Rose McGready; Anna Annerberg; Robert Hutagalung; Thida Singtoroj; Gilvary Hla; Al Brockman; Stephane Proux; Jahser Wilahphaingern; Pratap Singhasivanon; Nicholas J White; François Nosten
Journal:  Trop Med Int Health       Date:  2007-02       Impact factor: 2.622

8.  Liquid chromatography-tandem mass spectrometry for the simultaneous quantitation of artemether and lumefantrine in human plasma: application for a pharmacokinetic study.

Authors:  Isabela Costa César; José Antônio de Aquino Ribeiro; Leonardo de Souza Teixeira; Karini Bruno Bellorio; Fernanda Crunivel de Abreu; Josianny Mesquita Moreira; Paula Rocha Chellini; Gerson Antônio Pianetti
Journal:  J Pharm Biomed Anal       Date:  2010-08-17       Impact factor: 3.935

9.  Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper.

Authors:  D Blessborn; S Römsing; A Annerberg; D Sundquist; A Björkman; N Lindegardh; Y Bergqvist
Journal:  J Pharm Biomed Anal       Date:  2007-07-20       Impact factor: 3.935

10.  Determination of benflumetol in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.

Authors:  M Y Zeng; Z L Lu; S C Yang; M Zhang; J Liao; S L Liu; X H Teng
Journal:  J Chromatogr B Biomed Appl       Date:  1996-06-07
View more
  11 in total

1.  Semi-quantitative measurement of the antimalarial lumefantrine from untreated dried blood spots using LC-MS/MS.

Authors:  Matthew M Ippolito; Liusheng Huang; Mwiche Siame; Philip Thuma; Theresa A Shapiro; Francesca T Aweeka
Journal:  J Pharm Biomed Anal       Date:  2018-04-05       Impact factor: 3.935

2.  Determination of the antimalarial drug piperaquine in small volume pediatric plasma samples by LC-MS/MS.

Authors:  Linda L Kjellin; Grant Dorsey; Philip J Rosenthal; Francesca Aweeka; Liusheng Huang
Journal:  Bioanalysis       Date:  2014       Impact factor: 2.681

3.  Effect of Pregnancy on the Pharmacokinetic Interaction between Efavirenz and Lumefantrine in HIV-Malaria Coinfection.

Authors:  Adebanjo Adegbola; Rana Abutaima; Adeniyi Olagunju; Omotade Ijarotimi; Marco Siccardi; Andrew Owen; Julius Soyinka; Oluseye Bolaji
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

4.  Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.

Authors:  Jane Achan; Abel Kakuru; Gloria Ikilezi; Theodore Ruel; Tamara D Clark; Christian Nsanzabana; Edwin Charlebois; Francesca Aweeka; Grant Dorsey; Philip J Rosenthal; Diane Havlir; Moses R Kamya
Journal:  N Engl J Med       Date:  2012-11-29       Impact factor: 91.245

5.  Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.

Authors:  Emma Hughes; Norah Mwebaza; Liusheng Huang; Richard Kajubi; Vy Nguyen; Myaing M Nyunt; Francis Orukan; Moses W Mwima; Sunil Parikh; Francesca Aweeka
Journal:  J Acquir Immune Defic Syndr       Date:  2020-02-01       Impact factor: 3.771

6.  Therapeutic Efficacy of Artemether-Lumefantrine for Uncomplicated Falciparum Malaria in Northern Zambia.

Authors:  Matthew M Ippolito; Julia C Pringle; Mwiche Siame; Ben Katowa; Ozkan Aydemir; Peter O Oluoch; Liusheng Huang; Francesca T Aweeka; Jeffrey A Bailey; Jonathan J Juliano; Steven R Meshnick; Theresa A Shapiro; William J Moss; Philip E Thuma
Journal:  Am J Trop Med Hyg       Date:  2020-10-15       Impact factor: 3.707

Review 7.  Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data.

Authors: 
Journal:  BMC Med       Date:  2015-09-18       Impact factor: 8.775

8.  Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.

Authors:  Myaing M Nyunt; Vy K Nguyen; Richard Kajubi; Liusheng Huang; Joshua Ssebuliba; Sylvia Kiconco; Moses W Mwima; Jane Achan; Francesca Aweeka; Sunil Parikh; Norah Mwebaza
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

9.  Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.

Authors:  Sunil Parikh; Richard Kajubi; Liusheng Huang; Joshua Ssebuliba; Sylvia Kiconco; Qin Gao; Fangyong Li; Moses Were; Abel Kakuru; Jane Achan; Norah Mwebaza; Francesca T Aweeka
Journal:  Clin Infect Dis       Date:  2016-05-03       Impact factor: 9.079

10.  Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.

Authors:  Liusheng Huang; Vincent Carey; Jane C Lindsey; Florence Marzan; David Gingrich; Bobbie Graham; Linda Barlow-Mosha; Phionah K Ssemambo; Portia Kamthunzi; Sharon Nachman; Sunil Parikh; Francesca T Aweeka
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.